{
    "Trade/Device Name(s)": [
        "Dexcom G6 Glucose Program Continuous Glucose Monitoring System",
        "Dexcom G6 Continuous Glucose Monitoring System",
        "Dexcom Pro Q Continuous Glucose Monitoring System"
    ],
    "Submitter Information": "Dexcom, Inc.",
    "510(k) Number": "K191450",
    "Predicate Device Reference 510(k) Number(s)": [
        "K183206",
        "K182041",
        "K182405"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QBJ",
        "QDK",
        "QDL"
    ],
    "Summary Letter Date": "May 30, 2019",
    "Summary Letter Received Date": "May 31, 2019",
    "Submission Date": "May 30, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1355"
    ],
    "Regulation Name(s)": [
        "Integrated Continuous Glucose Monitoring System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Interstitial fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dexcom G6 sensor",
        "Dexcom BLE transmitter",
        "Mobile application",
        "Receiver device"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric measurement",
        "Glucose oxidase chemical reaction",
        "Bluetooth Low Energy data transmission"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Sensor",
        "Transmitter",
        "Mobile application",
        "Accessory",
        "Component",
        "Patch"
    ],
    "Document Summary": "FDA 510(k) summary for Dexcom G6, G6 Glucose Program, and Pro Q continuous glucose monitoring systems with alternative adhesive patch for management and retrospective analysis of glycemic control.",
    "Indications for Use Summary": "Real time or retrospective continuous glucose monitoring for management of diabetes or glycemic variability in persons aged 2 years and older, replacing fingerstick blood glucose testing, with connectivity to digitally connected devices including automated insulin dosing systems.",
    "fda_folder": "Clinical Chemistry"
}